# Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment

> **NCT01765244** · PHASE1,PHASE2 · COMPLETED · sponsor: **Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud** · enrollment: 16 (actual)

## Conditions studied

- Severe Trophic Corneal Ulcers Refractory to Conventional Treatment
- Sequelae of Previous Trophic Corneal Ulcers

## Interventions

- **DRUG:** Anterior lamellar nanostructured artificial human cornea.
- **OTHER:** Amniotic membrane transplantation

## Key facts

- **NCT ID:** NCT01765244
- **Lead sponsor:** Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-17
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-01-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765244, "Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01765244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*